[Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non-metastatic inflammatory breast cancer].

Hasbini, A; Le Péchoux, C; Roche, B; Pignol, J P; Zelek, L; Abdulkarim, B; Arriagada, R; Guinebretière, J M; Tardivon, A; Spielmann, M; Habrand, J L

[Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non-metastatic inflammatory breast cancer]. / Radiothérapie hyperfractionnée accélérée alternée avec une chimiothérapie dans le cancer du sein inflammatoire non métastatique.

Hasbini, A; Le Péchoux, C; Roche, B; Pignol, J P; Zelek, L; Abdulkarim, B; Arriagada, R; Guinebretière, J M; Tardivon, A; Spielmann, M; Habrand, J L.

Affiliation

Hasbini A; Département de radiothérapie, institut Gustave-Roussy, Villejuif, France.

Cancer Radiother ; 4(4): 265-73, 2000.

Article in Fr | MEDLINE | ID: mdl-10994390

Subject(s)

Adenocarcinoma/drug therapy; Adenocarcinoma/radiotherapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Breast Neoplasms/radiotherapy; Adult; Aged; Combined Modality Therapy; Cyclophosphamide/administration & dosage; Dose Fractionation, Radiation; Doxorubicin/administration & dosage; Epirubicin/administration & dosage; Female; Fluorouracil/administration & dosage; Humans; Methotrexate/administration & dosage; Middle Aged; Prospective Studies; Survival Analysis; Vincristine/administration & dosage

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: Fr Year: 2000 Type: Article

Search on Google

XML

PubMed Links